Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Int J Genomics
2020 Jan 01;2020:2061024. doi: 10.1155/2020/2061024.
Show Gene links
Show Anatomy links
Integrated Bioinformatic Analysis Identifies Networks and Promising Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma.
Ji Y
,
Yin Y
,
Zhang W
.
???displayArticle.abstract???
Chronic infection with hepatitis B virus (HBV) has long been recognized as a dominant hazard factor for hepatocellular carcinoma (HCC) and accounts for at least half of HCC instances globally. However, the underlying molecular mechanism of HBV-linked HCC has not been completely elucidated. Here, three microarray datasets, totally containing 170 tumoral samples and 181 adjacent normal tissues from the liver of patients suffering from HBV-related HCC assembled from the Gene Expression Omnibus (GEO) database, were subjected to integrated analysis of differentially expressed genes (DEGs). Subsequently, the analysis of function and pathway enrichment as well as the protein-protein interaction network (PPI) was performed. The ten hub genes screened out from the PPI network were further subjected to expression profile and survival analysis. Overall, 329 DEGs (67 upregulated and 262 downregulated) were identified. Ten DEGs with the highest degree of connectivity included cyclin-dependent kinase 1 (CDK1), cyclin B1 (CCNB1), cyclin B2 (CCNB2), PDZ-binding kinase (PBK), abnormal spindlemicrotubule assembly (ASPM), nuclear division cycle 80 (NDC80), aurora kinase A (AURKA), targeting protein for xenopus kinesin-like protein 2 (TPX2), kinesin family member 2C (KIF2C), and centromere protein F (CENPF). Kaplan-Meier analysis unveiled that overexpression levels of KIF2C and TPX2 were relevant to both the poor overall survival and relapse-free survival. In summary, the hub genes validated in the present study may provide promising targets for the diagnosis, prognosis, and therapy of HBV-associated HCC. Additionally, our work uncovers various crucial biological components (e.g., extracellular exosome) and signaling pathways that participate in the progression of HCC induced by HBV, serving comprehensive knowledge of the mechanisms regarding HBV-related HCC.
Figure 1. The workflow diagram of data acquisition, preprocessing, analysis, and validation.
Figure 2. Volcano plots and Venn diagrams of differentially expressed genes (DEGs) selected from three Gene Expression Omnibus (GEO) datasets. (a) Volcano plots of DEGs in normal and tumoral liver samples of HCC patients with HBV infection in GSE47197, GSE55092, and GSE121248. DEGs were filtered by adjusted P value < 0.05 and ∣log2 (fold change) | ≥1. The red and green dots display the distribution of all the significant upregulated (red dots) and downregulated (green dots) DEGs in the three datasets, respectively. (b, c) The Venn diagrams of overlapping DEGs from an intersection of upregulated and downregulated genes in the three datasets.
Figure 3. Gene Ontology (GO) enrichment analysis of DEGs following the evaluation by (a) the DAVID functional annotation and (b, c) ClueGO plugin. (a) The histogram with orange, green, and yellow shows GO terms Biological Process (BP), Cellular Component (CC), and Molecular Function (MF), respectively. (b) Functional connection of the enriched categories for DEGs (kappa score ≥ 0.4). The GO terms are depicted as nodes, whose size represents the degree of significance. (c) The pie chart shows the clusters of GO terms that were labeled with diverse colors.
Figure 4. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis of DEGs based on the DAVID functional annotation and ClueGO plugin of Cytoscape. (a) KEGG enrichment analyzed by DAVID is displayed by a scatter plot. (b) The network with terms connected to its kappa score point (≥0.4) as evaluated by the ClueGO plugin. (c) Overview of the chart containing the most significant KEGG terms with the corresponding colors.
Figure 5. Protein-protein interaction (PPI) network, hub gene screening, and module analysis. (a) The PPI network constructed using STRING 11.0 was visualized by Cytoscape. The upregulated genes are shown in green, while the downregulated genes are shown in bluish violet. (b) The network directly associated with the top ten hub genes identified by CytoHubba. (c) The network of the top ten hub genes filtered according to the degree method provided by CytoHubba. (d, e) The key modules identified using the MCODE plugin of Cytoscape, which contains 27 nodes/344 edges and 16 nodes/34 edges, respectively.
Figure 6. Validation of the expression level of the ten hub genes between the clinical liver samples from HBV-related HCC patients and those from healthy individuals. All the relative expression levels of hub genes were based on the dataset from Roessler et al., except for that of ASPM (Guichard et al.).
Figure 7. Kaplan-Meier plotter reveals the overall survival (OS) and relapse-free survival (RFS) curves with a significant difference concerning the hub genes in a liver cancer RNA-seq cohort. As risk factors, alcohol consumption was excluded and hepatitis virus was included in the analysis. The analysis was run on 111 and 103 patients for OS and RFS, respectively. P < 0.05 was considered a statistically significant difference.
Afshar-Kharghan,
The role of the complement system in cancer.
2017, Pubmed
Afshar-Kharghan,
The role of the complement system in cancer.
2017,
Pubmed
An,
Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma.
2018,
Pubmed
Ba,
Iron deprivation suppresses hepatocellular carcinoma growth in experimental studies.
2011,
Pubmed
Barrett,
NCBI GEO: archive for functional genomics data sets--update.
2013,
Pubmed
Bindea,
ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks.
2009,
Pubmed
Boroughs,
Metabolic pathways promoting cancer cell survival and growth.
2015,
Pubmed
Bray,
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
2018,
Pubmed
Cai,
Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties.
2017,
Pubmed
Chai,
FOXM1 promotes proliferation in human hepatocellular carcinoma cells by transcriptional activation of CCNB1.
2018,
Pubmed
Chen,
Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma.
2017,
Pubmed
Chen,
HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway.
2018,
Pubmed
Chen,
AURKA promotes cancer metastasis by regulating epithelial-mesenchymal transition and cancer stem cell properties in hepatocellular carcinoma.
2017,
Pubmed
Chen,
Examining the key genes and pathways in hepatocellular carcinoma development from hepatitis B virus‑positive cirrhosis.
2018,
Pubmed
Chen,
Identification of Potential Key Genes for Hepatitis B Virus-Associated Hepatocellular Carcinoma by Bioinformatics Analysis.
2019,
Pubmed
Cheng,
Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
2019,
Pubmed
Cheng,
Remission of hepatocellular carcinoma with arginine depletion induced by systemic release of endogenous hepatic arginase due to transhepatic arterial embolisation, augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma.
2005,
Pubmed
Cheng,
Hepatitis B virus X protein (HBx) induces G2/M arrest and apoptosis through sustained activation of cyclin B1-CDK1 kinase.
2009,
Pubmed
Chin,
cytoHubba: identifying hub objects and sub-networks from complex interactome.
2014,
Pubmed
Collins,
The cell cycle and cancer.
1997,
Pubmed
Coussens,
Inflammation and cancer.
,
Pubmed
Croft,
Reactome: a database of reactions, pathways and biological processes.
2011,
Pubmed
Dai,
Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma.
2013,
Pubmed
Davis,
GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor.
2007,
Pubmed
Di Ciaula,
Bile Acids and Cancer: Direct and Environmental-Dependent Effects.
2020,
Pubmed
Di Ciaula,
Bile Acids and Cancer: Direct and Environmental-Dependent Effects.
2017,
Pubmed
Enserink,
An overview of Cdk1-controlled targets and processes.
2010,
Pubmed
Fang,
Chk1-induced CCNB1 overexpression promotes cell proliferation and tumor growth in human colorectal cancer.
2014,
Pubmed
Gao,
Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma.
2015,
Pubmed
Gao,
Karyopherin subunit-α 2 expression accelerates cell cycle progression by upregulating CCNB2 and CDK1 in hepatocellular carcinoma.
2018,
Pubmed
Goel,
Understanding survival analysis: Kaplan-Meier estimate.
2010,
Pubmed
Guichard,
Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma.
2012,
Pubmed
Guo,
Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria.
2017,
Pubmed
Hai,
Role of hepatitis B virus DNA integration in human hepatocarcinogenesis.
2014,
Pubmed
Haider,
Novel inhibitors of cyclin-dependent kinases combat hepatocellular carcinoma without inducing chemoresistance.
2013,
Pubmed
He,
PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma.
2010,
Pubmed
Hong,
An Analysis of Immunoreactive Signatures in Early Stage Hepatocellular Carcinoma.
2015,
Pubmed
Hsu,
Targeting TPX2 Suppresses the Tumorigenesis of Hepatocellular Carcinoma Cells Resulting in Arrested Mitotic Phase Progression and Increased Genomic Instability.
2017,
Pubmed
Huang,
The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists.
2007,
Pubmed
Hvidberg,
Identification of the receptor scavenging hemopexin-heme complexes.
2005,
Pubmed
Issaeva,
p53 Signaling in Cancers.
2019,
Pubmed
Janeček,
Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2.
2016,
Pubmed
Ju,
Effect of NDC80 in human hepatocellular carcinoma.
2017,
Pubmed
Kew,
Hepatic iron overload and hepatocellular carcinoma.
2014,
Pubmed
Levrero,
Mechanisms of HBV-induced hepatocellular carcinoma.
2016,
Pubmed
Li,
Identification of breast cancer prognostic modules based on weighted protein-protein interaction networks.
2017,
Pubmed
Li,
Bioinformatics analysis to screen the key prognostic genes in ovarian cancer.
2017,
Pubmed
Li,
The Identification of Core Gene Expression Signature in Hepatocellular Carcinoma.
2018,
Pubmed
Li,
Cyclin B2 Overexpression in Human Hepatocellular Carcinoma is Associated with Poor Prognosis.
2019,
Pubmed
Lin,
ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
2008,
Pubmed
Liu,
ShRNA-mediated silencing of the Ndc80 gene suppress cell proliferation and affected hepatitis B virus-related hepatocellular carcinoma.
2016,
Pubmed
Liu,
TPX2 as a novel prognostic biomarker for hepatocellular carcinoma.
2015,
Pubmed
,
Xenbase
Lui,
Targeting cancer by binding iron: Dissecting cellular signaling pathways.
2015,
Pubmed
Mashouri,
Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance.
2019,
Pubmed
Menyhárt,
Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma.
2018,
Pubmed
Nagy,
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets.
2018,
Pubmed
Narrandes,
Gene Expression Detection Assay for Cancer Clinical Use.
2018,
Pubmed
Nath,
Transcriptional control of mitosis: deregulation and cancer.
2015,
Pubmed
Newman,
One-carbon metabolism in cancer.
2017,
Pubmed
Pestell,
Antibiotics for cancer therapy.
2015,
Pubmed
Ravindran Menon,
CDK1 Interacts with Sox2 and Promotes Tumor Initiation in Human Melanoma.
2018,
Pubmed
Rhodes,
ONCOMINE: a cancer microarray database and integrated data-mining platform.
2004,
Pubmed
Roessler,
A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients.
2010,
Pubmed
SZENT-GYOERGYI,
CELL DIVISION AND CANCER.
1965,
Pubmed
Saito,
A travel guide to Cytoscape plugins.
2012,
Pubmed
Salerno,
Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription.
2020,
Pubmed
Shannon,
Cytoscape: a software environment for integrated models of biomolecular interaction networks.
2003,
Pubmed
Shen,
Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
2019,
Pubmed
Sun,
Identification of core genes and outcome in gastric cancer using bioinformatics analysis.
2017,
Pubmed
Szklarczyk,
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.
2019,
Pubmed
Tang,
Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis.
2018,
Pubmed
Tang,
Overexpression of ASPM, CDC20, and TTK Confer a Poorer Prognosis in Breast Cancer Identified by Gene Co-expression Network Analysis.
2019,
Pubmed
Vettore,
New aspects of amino acid metabolism in cancer.
2020,
Pubmed
Wang,
Variations in the AURKA Gene: Biomarkers for the Development and Progression of Hepatocellular Carcinoma.
2018,
Pubmed
Wang,
Iron Metabolism in Cancer.
2018,
Pubmed
Wei,
RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin.
2014,
Pubmed
Weng,
Identification of cyclin B1 and Sec62 as biomarkers for recurrence in patients with HBV-related hepatocellular carcinoma after surgical resection.
2012,
Pubmed
Whiteside,
Tumor-Derived Exosomes and Their Role in Cancer Progression.
2016,
Pubmed
Wu,
Hepatitis C virus NS5A protein down-regulates the expression of spindle gene Aspm through PKR-p38 signaling pathway.
2008,
Pubmed
Wu,
Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma.
2018,
Pubmed
Xu,
Hepatitis B Virus-Related Hepatocellular Carcinoma: Pathogenic Mechanisms and Novel Therapeutic Interventions.
2014,
Pubmed
Yang,
PBK overexpression promotes metastasis of hepatocellular carcinoma via activating ETV4-uPAR signaling pathway.
2019,
Pubmed
Yang,
PDZ binding kinase, regulated by FoxM1, enhances malignant phenotype via activation of β-Catenin signaling in hepatocellular carcinoma.
2017,
Pubmed
Yu,
Enhanced construction of gene regulatory networks using hub gene information.
2017,
Pubmed
Zamor,
Viral hepatitis and hepatocellular carcinoma: etiology and management.
2017,
Pubmed
Zhang,
Exosomes: biogenesis, biologic function and clinical potential.
2019,
Pubmed